You are here
Ancillary Studies
- Getting Started
- Ancillary Study Policy
- Biospecimen Policy
- CHS Guidelines for Genetic Studies - June 2008
- CHS All Stars Ancillary Study
- Go directly to the Submission Page
Ancillary Study proposals must obtain CHS and NHLBI approval before submission to a funding agency.
To submit your proposal for review: Download the Ancillary Study Proposal form from the Forms & Agreements menu.
Instructions:
- New Data Collection studies: complete the full Ancillary Study Proposal form and send to Ancillary Studies Coordinator along with Lab's biorepository impact report (if relevant).
- Analysis-only studies: complete Part 1 only of the Ancillary Study Proposal form + first planned paper proposal (online submission form via internal site (password protected)). See also: step-by-step instructions.
Submission Deadlines:
- New proposals must be submitted to CHS a minimum of 6 weeks prior to a grant deadline, preferably earlier to allow time for revisions and re-review, if needed.
- New proposals involving subcontracts should be submitted well in advance of this 6-week deadline.
- Revised proposals are not subject to this deadline, although sufficient time for review and for potential further revision should still be provided.
- Agreement with the Coordinating Center and, if applicable, the CHS Central Laboratory about the costs needed to perform an ancillary study is required for Steering Committee approval.
The current NHLBI CHS contract (75N92021D00006) is scheduled to end October 31st, 2024. We are in discussion with NHLBI about the study close-out timeline, but it is possible that the upcoming CHS deadline of December 23, 2022 (adjusted due to holiday) for the February 5 NIH cycle will be the final acceptance date for CHS ancillary studies that request biospecimens.
Definition of an Ancillary Study
An ancillary study is an investigation which is not part of the central, NHLBI-funded CHS protocol but uses CHS participants, samples, or data collected by CHS. An ancillary study can involve acquisition of additional data which are not compiled as part of the standard CHS data set, or analysis of existing CHS data only in a paper or series of papers as part of a new external funding application.
Support for ancillary studies is derived from sources other than CHS grant or contract funds. Examples include studies funded by investigator-initiated NIH research awards (R01s), grants from academic institutions, private sources (e.g. drug companies), or those performed at no cost (generally because of the special interest of a researcher).
Rationale for Ancillary Studies
Investigators are encouraged to propose and conduct ancillary studies. Such studies enhance the value of CHS and ensure the continued interest of the diverse group of investigators who are critical to the success of the study as a whole. They provide an exceptional opportunity for investigators, either within or outside of CHS, to conduct additional projects at minimal cost.
Types of Ancillary Studies
There are two types of ancillary studies in CHS:
- New Data Collection studies generate new CHS data, either through new interaction with participants, or by using existing stored biological specimens, images, medical records, or previously collected data to create new measures.
- Analysis-only studies analyze existing CHS data only, in a paper or series of papers as part of a new external funding application, regardless of whether significant Coordinating Center (CC) services (e.g., data set preparation or analysis by a CC Statistician) are requested.
Questions? Please contact Erika Enright.
Related Links: